Cat.#: ACPP-1739
| Despition | SYT3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1344 | Olig2 Blocking Peptide (AC1344) | 250 µg | inquiry |
| ACPP-1737 | Human NCALD Protein (AC1737) | 5 µg | inquiry |
| ACPP-1305 | Aph 1b Blocking Peptide (AC1305) | 250 µg | inquiry |
| ACPP-1036 | Recombinant Human ANGPTL7 Protein (6×His Tag) (AC1036) | 50 µg | inquiry |
| ACPP-1233 | Galectin 3 Blocking Peptide (AC1233) | 250 µg | inquiry |
| ACPP-1807 | Human QKI Protein (AC1807) | 2 µg | inquiry |
| ACPP-1627 | Human Visfatin Protein, His (AC1627) | 5 µg | inquiry |
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
| ACPP-1635 | Human Leptin Protein (AC1635) | 200 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.